The report "Heparin Market by treatment type (unfractionated heparin, low molecular weight heparin (LMWH) and ultra-molecular weight heparin (UMWH), by route of administration (IV injection, subcutaneous injection), by applications, (Clinical trials, medical devices and venous Thromboembolism), by end user (hospital, blood and steam banks and others), and by region (North America, Europe, Asia-Pacific and RoW)", the Heparin market is expected to reach USD 13.44 billion by 2023 expanding at a CAGR of 5.91% between 2017 and 2023.